Clinical trial
Safety and Effectiveness of D-serine in Schizophrenia
NCT00322023 · Nathan Kline Institute for Psychiatric Research, Other · Completed
Key facts
| NCT number | NCT00322023 |
|---|---|
| Title | Safety and Effectiveness of D-serine in Schizophrenia |
| Official title | PK/PD Study of Escalating Dose D-serine as Adjunctive Treatment in Schizophrenia |
| Lead sponsor | Nathan Kline Institute for Psychiatric Research, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | D-serine |
| Enrollment | 55 |
| Start date | Mar 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | May 4, 2006 |
| Last update posted | Oct 5, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: